The Lens
 | |
Type of site | Patent Search Service |
|---|---|
| Available in | Multilingual |
| Owner | Cambia |
| URL | The Lens |
| Commercial | Not for profit |
| Registration | No |
| Launched | 2000 |
| Current status | Active |
The Lens, formerly called Patent Lens, is a free searcheable online patent and scholarly literature database, provided by Cambia, an Australia-based non-profit organization. The Lens has been hailed as the “most comprehensive scholarly literature database, that exceeds in its width and depth two leading commercial databases (Web of Science and Scopus) combined”.[1] The Lens is an agglomeration database, that takes bibliometric data from other databases (such as Crossref, PubMed, Microsoft Academic and Open Alex ) and combines them into one, deduplicated (albeit not perfectly) and with a powerful unified search syntax.
Launched in 2000 as the Patent Lens, over the years, thanks to grants from the Rockefeller Foundation in 2000–2004, Bill and Melinda Gates Foundation in 2011, Gordon and Betty Moore Foundation in 2012, Wellcome Trust in 2018, as well as from the Lemelson Foundation it added journal articles, conference papers, reports, books and other types of scholarly literature,[2][3][4][1] and evolved into a comprehensive database with over 225+ million scholarly works, 127+ million global patent records, and more than 370 million biological sequences, all with unprecedentedly rich metadata (including citations).[5]
In 2013, the Patent Lens was officially replaced with Cambia's new site The Lens.[citation needed]
Features
[edit]The four main advantages of The Lense compared to the leading commercial scholarly databases (e.g. Web of Science and Scopus) are:
1) The Lense is available for anyone with an internet access, and it is free, while commercial databases require quite expensive subscription fees, and in practice they are accessible only to a small number of people affiliated with major research or educational institutions.
2) There are no restrictions on the type and amount of data, that can be exported from The Lens, while all commercial databases have export restrictions.
3) Albeit The Lense does not allow comprehensive SQL-type searches, it employs a combination of Apache Lucene and ElasticSearch search synthax,[6] which is more powerful than the search capabilities of Scopus, Web of Science and SciFinder.
4) Also, unlike the competing databases, The Lens allows data exporting in JSON format with a superior granularity compared to RIS and CSV formats.
The Lens currently links to regulatory data in the form of the United States Food and Drug Administration (FDA) Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.[7] Biological sequence data is integrated via links to National Center for Biotechnology Information (NCBI) GenBank and the Patent Lens's own gene sequences. The Patent Lens Sequence Project,[8] commenced in June 2006, provides the only public facility to enable users to explore over 80 million DNA and protein sequences disclosed in patents.[9]
The Lens allows for Patent searches using specific document sections, such as title, abstract, inventor, applicant/assignee, publication number, filing number and full-text. A user is also able to search for lapsed, abandoned, or expired US patents via the INPADOC patent status and family information service. Patent families may be visualized using graphical trees as PDF files. Nevertheless, the granularity of the Lens search function is inferior to that of commercial database Questel-Orbit.[10]
Patent tutorials[11] are available on the site covering patent claims, freedom to operate, patent inventorship, and continuing patent applications. Plant breeders' rights (PBR), also known as plant variety rights (PVR), are also addressed. This has the intention to "forge a learning resource that participants in innovation systems at all levels... can use to learn of critical and timely issues relevant to improving the public good... by engaging with the patent system".[12]
Native language support
[edit]The patent search interface is available in Chinese, English and French, with the full text of European Patent Office (EPO) patents being searchable in English, French and German. PCT applications are searchable in Chinese, English, French, German, Japanese, Korean, Russian and Spanish.
Technology landscapes
[edit]In addition to the patent search engine, the Lens also hosts a number of "technology landscapes".[13] These landscapes analyse volumes of specialized patent, scientific, technical and business data around particular topics into a more navigable form.
In the field of health and medicine, landscapes have been created for human genome patenting, the influenza genome, the human Telomerase gene, molecular markers outside gene sequences, and adjuvants. For agriculture and the environment, landscapes exist to describe the Agrobacterium-mediated transformation of plants, promoters used to regulate gene expression, antibiotic resistance genes and their uses in plant genetic transformation, resistance to Phosphinothricin, positive selection, bioindicators/ambiosensors, and the rice genome.
Since 2005 the Patent Lens database has been fully navigable, interactive, and updatable by users.
Endorsement
[edit]The landscaping activities of the Patent Lens have been endorsed by Francis Gurry, director general of the World Intellectual Property Organization (WIPO) in March 2009, in "view of the shared objective of making patent information systems more comprehensive and accessible, and turning raw patent data into useful information resources so as to strengthen the empirical basis of international policy processes".[14]
Nature Biotechnology called the Patent Lens "a giant leap in the right direction" for providing researchers, technology transfer offices and company executives a facile means of establishing the novelty of their offerings and the nature of their competitors' inventions.[15]
See also
[edit]References
[edit]- ^ a b Penfold, R. (2020). "Using the Lens Database for Staff Publications." Journal of the Medical Library Association 108(2): 341-344}
- ^ "Which Institutions are Behind the Lens". about.lens.org.
- ^ "Our History - When Was It Started". about.lens.org.
- ^ {Editorial (2006). "Patently transparent." Nature Biotechnology 24(5): 474
- ^ "What". About The Lens.
- ^ "Search Syntax – The Lens". support.lens.org.
- ^ "United States Food and Drug Administration Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations". Retrieved 2010-01-04.
- ^ "Cambia's Sequence Project". Archived from the original on 2009-10-12. Retrieved 2010-01-04.
- ^ Connett Porceddu, MB, Bacon, N, Ashton, D, Baillie, B, dos Remedios, N, Wei, Y, Jefferson, RA (2007). "Constructive approaches to Intellectual Property Complexity in Today's Agricultural Technology World" (PDF). Plant Molecular Breeding. 5 (2): 294–295. Archived from the original (PDF) on 2008-11-21. Retrieved 2010-01-04.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ https://www.orbit.com%7CQuestel
- ^ "Patent Tutorials and FAQs". Archived from the original on 2010-03-25. Retrieved 2010-01-04.
- ^ Jefferson, Richard (Fall 2006). "Science as Social Enterprise: The CAMBIA BiOS Initiative". Innovations. 1 (4): 13–44. doi:10.1162/itgg.2006.1.4.13. hdl:2123/2686.
- ^ "Patent Lens Technology Landscapes". Retrieved 2010-01-04.[permanent dead link]
- ^ "Patent Lens Letter of Endorsement from Dr. Francis Gurry, Director General, World Intellectual Property Organization (WIPO)" (PDF). Archived from the original (PDF) on 2009-10-24. Retrieved 2010-01-04.
- ^ "Patently Transparent". Nature Biotechnology. 24 (5): 474. 2006. doi:10.1038/nbt0506-474a. PMID 16680110.